MP
NVO

McDonald Partners’s Novo Nordisk NVO Stock Holding History

McDonald Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.6K Buy
+1,347
New +$57.9K 0.02% 310
2022
Q1 		– Sell
-48
Closed -$2.69K – 574
2021
Q4 		$2.69K Buy
+48
New +$2.6K ﹤0.01% 307

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

McDonald Partners's NVO Position: Q2 2026 in Review

McDonald Partners opened a new position in Novo Nordisk (NVO) in Q2 2026: 1,347 shares worth $64.6K. The stake represents 0.02% of the portfolio and ranks #310 among its holdings. This is a return to the name: McDonald Partners previously reported a position in NVO as recently as Q4 2021.

McDonald Partners first reported a position in NVO in Q4 2021 and has held it in 2 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • McDonald Partners held 1,347 shares of Novo Nordisk worth $64.6K as of Q2 2026.
  • Novo Nordisk was a new McDonald Partners position in Q2 2026.
  • Novo Nordisk made up 0.02% of McDonald Partners's portfolio in Q2 2026, its #310 holding.
  • McDonald Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 2 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.